These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25313690)

  • 1. A Combination Therapy of Nicotinamide and Progesterone Improves Functional Recovery following Traumatic Brain Injury.
    Peterson TC; Hoane MR; McConomy KS; Farin FM; Bammler TK; MacDonald JW; Kantor ED; Anderson GD
    J Neurotrauma; 2015 Jun; 32(11):765-79. PubMed ID: 25313690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in chronic nicotinamide treatment after traumatic brain injury can alter components of functional recovery independent of histological damage.
    Hoane MR; Pierce JL; Kaufman NA; Beare JE
    Oxid Med Cell Longev; 2008; 1(1):46-53. PubMed ID: 19794908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effects of nicotinamide and progesterone on functional recovery of cognitive behavior following cortical contusion injury in the rat.
    Peterson TC; Anderson GD; Kantor ED; Hoane MR
    J Neurotrauma; 2012 Dec; 29(18):2823-30. PubMed ID: 23016598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinamide treatment induces behavioral recovery when administered up to 4 hours following cortical contusion injury in the rat.
    Hoane MR; Pierce JL; Holland MA; Anderson GD
    Neuroscience; 2008 Jun; 154(3):861-8. PubMed ID: 18514428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained delivery of nicotinamide limits cortical injury and improves functional recovery following traumatic brain injury.
    Goffus AM; Anderson GD; Hoane M
    Oxid Med Cell Longev; 2010; 3(2):145-52. PubMed ID: 20716938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical efficacy testing in middle-aged rats: nicotinamide, a novel neuroprotectant, demonstrates diminished preclinical efficacy after controlled cortical impact.
    Swan AA; Chandrashekar R; Beare J; Hoane MR
    J Neurotrauma; 2011 Mar; 28(3):431-40. PubMed ID: 21083416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of hypertonic saline and nicotinamide on sensorimotor and cognitive function following cortical contusion injury in the rat.
    Quigley A; Tan AA; Hoane MR
    Brain Res; 2009 Dec; 1304():138-48. PubMed ID: 19781534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nicotinamide on spatial memory and inflammation after juvenile traumatic brain injury.
    Smith AC; Holden RC; Rasmussen SM; Hoane MR; Hylin MJ
    Behav Brain Res; 2019 May; 364():123-132. PubMed ID: 30771366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide treatment provides acute neuroprotection and GFAP regulation following fluid percussion injury.
    Holland MA; Tan AA; Smith DC; Hoane MR
    J Neurotrauma; 2008 Feb; 25(2):140-52. PubMed ID: 18260797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous nicotinamide administration improves behavioral recovery and reduces lesion size following bilateral frontal controlled cortical impact injury.
    Vonder Haar C; Anderson GD; Hoane MR
    Behav Brain Res; 2011 Oct; 224(2):311-7. PubMed ID: 21704653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of progesterone following a moderate unilateral cortical contusion injury.
    Gilmer LK; Roberts KN; Scheff SW
    J Neurotrauma; 2008 Jun; 25(6):593-602. PubMed ID: 18476780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone and vitamin D: Improvement after traumatic brain injury in middle-aged rats.
    Tang H; Hua F; Wang J; Sayeed I; Wang X; Chen Z; Yousuf S; Atif F; Stein DG
    Horm Behav; 2013 Aug; 64(3):527-38. PubMed ID: 23896206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone and low-dose vitamin D hormone treatment enhances sparing of memory following traumatic brain injury.
    Hua F; Reiss JI; Tang H; Wang J; Fowler X; Sayeed I; Stein DG
    Horm Behav; 2012 Apr; 61(4):642-51. PubMed ID: 22570859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with vitamin B3 improves functional recovery and reduces GFAP expression following traumatic brain injury in rats.
    Hoane MR; Akstulewicz SL; Toppen J
    J Neurotrauma; 2003 Nov; 20(11):1189-99. PubMed ID: 14651806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone treatment improves cognitive outcome following experimental traumatic brain injury in rats.
    Si D; Wang H; Wang Q; Zhang C; Sun J; Wang Z; Zhang Z; Zhang Y
    Neurosci Lett; 2013 Oct; 553():18-23. PubMed ID: 23954829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the neurotherapeutic potential of a water-soluble progesterone analog after traumatic brain injury in rats.
    Wali B; Sayeed I; Guthrie DB; Natchus MG; Turan N; Liotta DC; Stein DG
    Neuropharmacology; 2016 Oct; 109():148-158. PubMed ID: 27267687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tapered progesterone withdrawal enhances behavioral and molecular recovery after traumatic brain injury.
    Cutler SM; Pettus EH; Hoffman SW; Stein DG
    Exp Neurol; 2005 Oct; 195(2):423-9. PubMed ID: 16039652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone treatment alters neurotrophin/proneurotrophin balance and receptor expression in rats with traumatic brain injury.
    Cekic M; Johnson SJ; Bhatt VH; Stein DG
    Restor Neurol Neurosci; 2012; 30(2):115-26. PubMed ID: 22232032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining Enriched Environment, Progesterone, and Embryonic Neural Stem Cell Therapy Improves Recovery after Brain Injury.
    Nudi ET; Jacqmain J; Dubbs K; Geeck K; Salois G; Searles MA; Smith JS
    J Neurotrauma; 2015 Jul; 32(14):1117-29. PubMed ID: 25268854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The enantiomer of progesterone acts as a molecular neuroprotectant after traumatic brain injury.
    VanLandingham JW; Cutler SM; Virmani S; Hoffman SW; Covey DF; Krishnan K; Hammes SR; Jamnongjit M; Stein DG
    Neuropharmacology; 2006 Nov; 51(6):1078-85. PubMed ID: 16926035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.